Fundamental dimension Equity attribute | ELANPeer $22.52▼-0.75% Cap $11.25BP/E -54.9x QuantScore42/100 | IDXXLeader $560.38▼-1.13% Cap $44.15BP/E 39.4x QuantScore57/100 | MRKPeer $144.63▼-1.77% Cap $356.8BP/E 114.8x QuantScore52/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
57/100 |
75/100 |
79/100 |
Valuation Multiples, PEG & DCF upside | 46/100 | 34/100 | 50/100 |
Health Piotroski, Altman Z, leverage & liquidity | 40/100 | 78/100 | 42/100 |
Growth Revenue / earnings growth & margins | 25/100 | 46/100 | 33/100 |
Sentiment Analyst ratings, targets & revisions | 40/100 | 53/100 | 56/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -54.9x | 39.4x | 114.8x |
Forward P/E (next FY) | 19.8x | 37.9x | 54.6x |
EV / EBITDA (TTM) | 18.9x | 27.8x | 29.0x |
Price / Sales | 2.2x | 9.7x | 5.4x |
Price / Free Cash Flow | 29.7x | 35.3x | 22.2x |
PEG ratio | 0.35 | 2.23 | -1.42 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 9 / 9 | 5 / 9 |
Altman Z-Score | 1.32 (Distress) | 20.19 (Safe) | 3.99 (Safe) |
Total debt / equity | 0.59 | 0.68 | 1.29 |
Quick ratio | 1.1x | 0.9x | 1.1x |
Interest coverage | 1.8x | 37.3x | 8.8x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +6.2% | +10.4% | +1.2% |
Net income growth YoY | -168.6% | +19.3% | +6.6% |
Gross margin (TTM) | 52.6% | 62.4% | 75.4% |
Operating margin (FY) | 5.3% | 31.6% | 36.2% |
FCF margin (FY) | 6.0% | 24.5% | 19.0% |
5. Trailing price performancePrice change over period |
1M return | +0.8% | +7.9% | -1.8% |
3M return | -9.6% | +3.0% | +10.8% |
6M return | -1.0% | -1.0% | +29.8% |
Year to date | -0.5% | -17.2% | +38.0% |
1Y return | +2.1% | -13.4% | +66.0% |
3Y return | +148.0% | +35.8% | +41.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $4.82 -78.6% premium | $166.05 -70.4% premium | $174.52 +20.7% upside |
Wall Street consensus target | $26.67 +18.4% · range $24.00–$30.00 | $690.00 +23.1% · range $620.00–$740.00 | $157.94 +9.2% · range $105.00–$180.00 |
Consensus stance | 68% Buy23% Hold9% Sell | 57% Buy39% Hold4% Sell | 68% Buy29% Hold3% Sell |